Open Access
How to translate text using browser tools
1 July 1989 USE OF TELAZOL® TO IMMOBILIZE FEMALE NORTHERN SEA LIONS (EUMETOPIAS JUBATUS) IN ALASKA
Thomas R. Loughlin, Terry Spraker
Author Affiliations +
Abstract

Twenty-nine female northern sea lions (Eumetopias jubatus) were immobilized using Telazol® in dosages ranging from 1.8 to 8.1 mg/kg. Best results were achieved with Telazol® dosages ranging between 1.8 and 2.5 mg/kg which resulted in smooth induction and recovery. Optimal injection location was in the muscle mass of the lower back and hip. Dosages >3.5 mg/kg resulted in a tendency toward hypothermia. Six mortalities occurred which were partially caused by the location of drug injection and perhaps the high dosage.

Loughlin and Spraker: USE OF TELAZOL® TO IMMOBILIZE FEMALE NORTHERN SEA LIONS (EUMETOPIAS JUBATUS) IN ALASKA
Thomas R. Loughlin and Terry Spraker "USE OF TELAZOL® TO IMMOBILIZE FEMALE NORTHERN SEA LIONS (EUMETOPIAS JUBATUS) IN ALASKA," Journal of Wildlife Diseases 25(3), 353-358, (1 July 1989). https://doi.org/10.7589/0090-3558-25.3.353
Received: 15 November 1988; Published: 1 July 1989
KEYWORDS
anesthetic
chemical immobilization
Eumetopias jubatus
field study
northern sea lions
otariids
Telazol®
Back to Top